284 related articles for article (PubMed ID: 31673874)
1. Shortening heparan sulfate chains prolongs survival and reduces parenchymal plaques in prion disease caused by mobile, ADAM10-cleaved prions.
Aguilar-Calvo P; Sevillano AM; Bapat J; Soldau K; Sandoval DR; Altmeppen HC; Linsenmeier L; Pizzo DP; Geschwind MD; Sanchez H; Appleby BS; Cohen ML; Safar JG; Edland SD; Glatzel M; Nilsson KPR; Esko JD; Sigurdson CJ
Acta Neuropathol; 2020 Mar; 139(3):527-546. PubMed ID: 31673874
[TBL] [Abstract][Full Text] [Related]
2. Neuronal Ndst1 depletion accelerates prion protein clearance and slows neurodegeneration in prion infection.
Aguilar-Calvo P; Malik A; Sandoval DR; Barback C; Orrù CD; Standke HG; Thomas OR; Dwyer CA; Pizzo DP; Bapat J; Soldau K; Ogawa R; Riley MB; Nilsson KPR; Kraus A; Caughey B; Iliff JJ; Vera DR; Esko JD; Sigurdson CJ
PLoS Pathog; 2023 Sep; 19(9):e1011487. PubMed ID: 37747931
[TBL] [Abstract][Full Text] [Related]
3. Prion protein glycans reduce intracerebral fibril formation and spongiosis in prion disease.
Sevillano AM; Aguilar-Calvo P; Kurt TD; Lawrence JA; Soldau K; Nam TH; Schumann T; Pizzo DP; Nyström S; Choudhury B; Altmeppen H; Esko JD; Glatzel M; Nilsson KPR; Sigurdson CJ
J Clin Invest; 2020 Mar; 130(3):1350-1362. PubMed ID: 31985492
[TBL] [Abstract][Full Text] [Related]
4. Enhanced neuroinvasion by smaller, soluble prions.
Bett C; Lawrence J; Kurt TD; Orru C; Aguilar-Calvo P; Kincaid AE; Surewicz WK; Caughey B; Wu C; Sigurdson CJ
Acta Neuropathol Commun; 2017 Apr; 5(1):32. PubMed ID: 28431576
[TBL] [Abstract][Full Text] [Related]
5. Prion protein post-translational modifications modulate heparan sulfate binding and limit aggregate size in prion disease.
Callender JA; Sevillano AM; Soldau K; Kurt TD; Schumann T; Pizzo DP; Altmeppen H; Glatzel M; Esko JD; Sigurdson CJ
Neurobiol Dis; 2020 Aug; 142():104955. PubMed ID: 32454127
[TBL] [Abstract][Full Text] [Related]
6. Glycosaminoglycan sulphation affects the seeded misfolding of a mutant prion protein.
Lawson VA; Lumicisi B; Welton J; Machalek D; Gouramanis K; Klemm HM; Stewart JD; Masters CL; Hoke DE; Collins SJ; Hill AF
PLoS One; 2010 Aug; 5(8):e12351. PubMed ID: 20808809
[TBL] [Abstract][Full Text] [Related]
7. Heparan sulfate is a cellular receptor for purified infectious prions.
Horonchik L; Tzaban S; Ben-Zaken O; Yedidia Y; Rouvinski A; Papy-Garcia D; Barritault D; Vlodavsky I; Taraboulos A
J Biol Chem; 2005 Apr; 280(17):17062-7. PubMed ID: 15668247
[TBL] [Abstract][Full Text] [Related]
8. Generation of novel neuroinvasive prions following intravenous challenge.
Aguilar-Calvo P; Bett C; Sevillano AM; Kurt TD; Lawrence J; Soldau K; Hammarström P; Nilsson KPR; Sigurdson CJ
Brain Pathol; 2018 Nov; 28(6):999-1011. PubMed ID: 29505163
[TBL] [Abstract][Full Text] [Related]
9. Sulfated glycosaminoglycans mediate prion-like behavior of p53 aggregates.
Iwahashi N; Ikezaki M; Nishikawa T; Namba N; Ohgita T; Saito H; Ihara Y; Shimanouchi T; Ino K; Uchimura K; Nishitsuji K
Proc Natl Acad Sci U S A; 2020 Dec; 117(52):33225-33234. PubMed ID: 33318190
[TBL] [Abstract][Full Text] [Related]
10. PrP aggregation can be seeded by pre-formed recombinant PrP amyloid fibrils without the replication of infectious prions.
Barron RM; King D; Jeffrey M; McGovern G; Agarwal S; Gill AC; Piccardo P
Acta Neuropathol; 2016 Oct; 132(4):611-24. PubMed ID: 27376534
[TBL] [Abstract][Full Text] [Related]
11. Defining the conformational features of anchorless, poorly neuroinvasive prions.
Bett C; Kurt TD; Lucero M; Trejo M; Rozemuller AJ; Kong Q; Nilsson KP; Masliah E; Oldstone MB; Sigurdson CJ
PLoS Pathog; 2013; 9(4):e1003280. PubMed ID: 23637596
[TBL] [Abstract][Full Text] [Related]
12. Anchorless risk or released benefit? An updated view on the ADAM10-mediated shedding of the prion protein.
Mohammadi B; Song F; Matamoros-Angles A; Shafiq M; Damme M; Puig B; Glatzel M; Altmeppen HC
Cell Tissue Res; 2023 Apr; 392(1):215-234. PubMed ID: 35084572
[TBL] [Abstract][Full Text] [Related]
13. Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins.
Asante EA; Gowland I; Grimshaw A; Linehan JM; Smidak M; Houghton R; Osiguwa O; Tomlinson A; Joiner S; Brandner S; Wadsworth JDF; Collinge J
J Gen Virol; 2009 Mar; 90(Pt 3):546-558. PubMed ID: 19218199
[TBL] [Abstract][Full Text] [Related]
14. Anchorless prion protein results in infectious amyloid disease without clinical scrapie.
Chesebro B; Trifilo M; Race R; Meade-White K; Teng C; LaCasse R; Raymond L; Favara C; Baron G; Priola S; Caughey B; Masliah E; Oldstone M
Science; 2005 Jun; 308(5727):1435-9. PubMed ID: 15933194
[TBL] [Abstract][Full Text] [Related]
15. Type I interferon protects neurons from prions in in vivo models.
Ishibashi D; Homma T; Nakagaki T; Fuse T; Sano K; Satoh K; Mori T; Atarashi R; Nishida N
Brain; 2019 Apr; 142(4):1035-1050. PubMed ID: 30753318
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis of cerebral neurodegeneration in prion diseases.
Tatzelt J; Schätzl HM
FEBS J; 2007 Feb; 274(3):606-11. PubMed ID: 17288549
[TBL] [Abstract][Full Text] [Related]
17. Production of seedable Amyloid-β peptides in model of prion diseases upon PrP
Ezpeleta J; Baudouin V; Arellano-Anaya ZE; Boudet-Devaud F; Pietri M; Baudry A; Haeberlé AM; Bailly Y; Kellermann O; Launay JM; Schneider B
Nat Commun; 2019 Aug; 10(1):3442. PubMed ID: 31371707
[TBL] [Abstract][Full Text] [Related]
18. Copper-dependent co-internalization of the prion protein and glypican-1.
Cheng F; Lindqvist J; Haigh CL; Brown DR; Mani K
J Neurochem; 2006 Sep; 98(5):1445-57. PubMed ID: 16923158
[TBL] [Abstract][Full Text] [Related]
19. Prion, amyloid beta-derived Cu(II) ions, or free Zn(II) ions support S-nitroso-dependent autocleavage of glypican-1 heparan sulfate.
Mani K; Cheng F; Havsmark B; Jönsson M; Belting M; Fransson LA
J Biol Chem; 2003 Oct; 278(40):38956-65. PubMed ID: 12732622
[TBL] [Abstract][Full Text] [Related]
20. Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases.
Morales R; Estrada LD; Diaz-Espinoza R; Morales-Scheihing D; Jara MC; Castilla J; Soto C
J Neurosci; 2010 Mar; 30(13):4528-35. PubMed ID: 20357103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
